Evidence map›Paper›PMID 27771849›Full record

ArticleJournal of natural medicines2017

Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats.

Phakhamon Lapphanichayakool, Manote Sutheerawattananonda, Nanteetip Limpeanchob

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sericin Protein: Structure, Properties, and Applications.Journal of functional biomaterials · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Fermented milks with specificJournal of food science and technology · 2023
    Article
  12. Article
  13. Article
  14. Heliyon · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Bioactive Peptides.Foods (Basel, Switzerland) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Phakhamon LapphanichayakoolDepartment of Pharmacy Practice, Faculty of Pharmaceutical Science, Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok, 65000, Thailand.
Manote SutheerawattananondaDepartment of Food Technology, Suranaree University of Technology, Nakhon Ratchasima, 30000, Thailand.
Nanteetip LimpeanchobDepartment of Pharmacy Practice, Faculty of Pharmaceutical Science, Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok, 65000, Thailand. nanteetipl@nu.ac.th.
Naresuan University · THSuranaree University of Technology · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The beneficial effect of cholesterol-lowering proteins and/or peptides derived from various dietary sources is continuously reported. A non-dietary protein from silk cocoon, sericin, has also demonstrated cholesterol-lowering activity. A sericin hydrolysate prepared by enzymatic hydrolysis was also expected to posses this effect. The present study was aimed at investigating the cholesterol-lowering effect of sericin peptides, so called "sericin-derived oligopeptides" (SDO) both in vivo and in vitro. The results showed that SDO at all three doses tested (10 mg kg

Indexed as

AnimalsCaco-2 CellsCholesterolDisease Models, AnimalHumansHypercholesterolemiaMaleOligopeptidesRatsRats, Sprague-DawleyRats, WistarSericinsTriglyceridesCholesterolOligopeptidesSericinsTriglyceridesBile acid bindingCholesterolHypocholesterolemic effectMicellar solubilityProtein hydrolysateSericin

Identifiers

PMID27771849
OpenAlexW2537259891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.